A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older (mRNA-1273-P301)

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

Outpatient CTRC
University of Colorado Hospital

Study ID

Protocol Number: 20-1619

More information available at ClinicalTrials.gov: NCT04470427

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers